Skip to content
- Implementing digital systems to facilitate genetic testing for hereditary cancer syndromes: An observational study of four clinical workflows.
- Wang C, Lu H, Bowen DJ, Xuan Z.
- Genet Med. 2023 Feb 10:S1098-3600(23)00815-8. doi: 10.1016/j.gim.2023.100802. Epub ahead of print.
- Breast Cancer Risk Assessment Tools for Stratifying Women into Risk Groups: A Systematic Review.
- Velentzis LS, Freeman V, Campbell D, Hughes S, Luo Q, Steinberg J, Egger S, Mann GB, Nickson C.
- Cancers (Basel). 2023 Feb 9;15(4):1124. doi: 10.3390/cancers15041124.
- Homologous recombination deficiency prediction using low-pass whole genome sequencing in breast cancer.
- Liu Y, Li Y, Zhang MZ, Chen D, Leng Y, Wang J, Han BW, Wang J.
- Cancer Genet. 2023 Feb 4;272-273:35-40. doi: 10.1016/j.cancergen.2023.02.001. Epub ahead of print.
- Proactive breast cancer risk assessment in primary care: a review based on the principles of screening.
- Usher-Smith JA, Hindmarch S, French DP, Tischkowitz M, Moorthie S, Walter FM, Dennison RA, Stutzin Donoso F, Archer S, Taylor L, Emery J, Morris S, Easton DF, Antoniou AC.
- Br J Cancer. 2023 Feb 3:1–11. doi: 10.1038/s41416-023-02145-w. Epub ahead of print.
- Atypical ATMs: Broadening the Phenotypic Spectrum of ATM-associated Hereditary Cancer.
- Borja NA, Silva-Smith R, Huang M, Parekh DJ, Sussman D, Tekin M.
- Front Oncol. 2023 Feb 3;13:1068110. doi: 10.3389/fonc.2023.1068110.